These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
177 related articles for article (PubMed ID: 2980513)
1. Relation between tissue nature and (18F) fluorodeoxyglucose kinetics evaluated by dynamic positron emission tomography in human brain tumors. Yamaguchi T; Sasaki H; Ogawa T; Mineura K; Uemura K; Kanno I; Shishido F; Murakami M; Inugami A; Higano S Acta Radiol Suppl; 1986; 369():415-8. PubMed ID: 2980513 [TBL] [Abstract][Full Text] [Related]
2. Independent thallium-201 accumulation and fluorine-18-fluorodeoxyglucose metabolism in glioma. Oriuchi N; Tomiyoshi K; Inoue T; Ahmad K; Sarwar M; Tokunaga M; Suzuki H; Watanabe N; Hirano T; Horikoshi S; Shibasaki T; Tamura M; Endo K J Nucl Med; 1996 Mar; 37(3):457-62. PubMed ID: 8772644 [TBL] [Abstract][Full Text] [Related]
3. Glucose consumption in recurrent gliomas. Ishikawa M; Kikuchi H; Miyatake S; Oda Y; Yonekura Y; Nishizawa S Neurosurgery; 1993 Jul; 33(1):28-33. PubMed ID: 8355844 [TBL] [Abstract][Full Text] [Related]
4. Tomographic mapping of kinetic rate constants in the fluorodeoxyglucose model using dynamic positron emission tomography. Sasaki H; Kanno I; Murakami M; Shishido F; Uemura K J Cereb Blood Flow Metab; 1986 Aug; 6(4):447-54. PubMed ID: 3488323 [TBL] [Abstract][Full Text] [Related]
5. [Positron emission tomographic evaluations on hemodynamics and glucose metabolism of brain tumors and perifocal edematous tissues]. Mizukawa N; Hino A; Imahori Y; Tenjin H; Yano I; Yoshino E; Hirakawa K; Yamashita M; Oki F; Nakahashi H No To Shinkei; 1989 Mar; 41(3):251-8. PubMed ID: 2787998 [TBL] [Abstract][Full Text] [Related]
6. Glucose consumption and rate constants for 18F-fluorodeoxyglucose in human gliomas. Ishikawa M; Kikuchi H; Nagata I; Yamagata S; Taki W; Yonekura Y; Nishizawa S; Iwasaki Y; Mukai T Neurol Med Chir (Tokyo); 1990 Jun; 30(6):377-81. PubMed ID: 1700316 [TBL] [Abstract][Full Text] [Related]
7. The in vivo metabolic pattern of low-grade brain gliomas: a positron emission tomographic study using 18F-fluorodeoxyglucose and 11C-L-methylmethionine. Derlon JM; Petit-Taboué MC; Chapon F; Beaudouin V; Noël MH; Creveuil C; Courtheoux P; Houtteville JP Neurosurgery; 1997 Feb; 40(2):276-87; discussion 287-8. PubMed ID: 9007859 [TBL] [Abstract][Full Text] [Related]
8. Uncoupling of hexose transport and phosphorylation in human gliomas demonstrated by PET. Herholz K; Ziffling P; Staffen W; Pawlik G; Wagner R; Wienhard K; Heiss WD Eur J Cancer Clin Oncol; 1988 Jul; 24(7):1139-50. PubMed ID: 3262062 [TBL] [Abstract][Full Text] [Related]
9. Identification of early recurrence of primary central nervous system tumors by [18F]fluorodeoxyglucose positron emission tomography. Glantz MJ; Hoffman JM; Coleman RE; Friedman AH; Hanson MW; Burger PC; Herndon JE; Meisler WJ; Schold SC Ann Neurol; 1991 Apr; 29(4):347-55. PubMed ID: 1929205 [TBL] [Abstract][Full Text] [Related]
10. Optimal cutoff levels of F-18 fluorodeoxyglucose uptake in the differentiation of low-grade from high-grade brain tumors with PET. Delbeke D; Meyerowitz C; Lapidus RL; Maciunas RJ; Jennings MT; Moots PL; Kessler RM Radiology; 1995 Apr; 195(1):47-52. PubMed ID: 7892494 [TBL] [Abstract][Full Text] [Related]
11. FDG transport and phosphorylation in human gliomas measured with dynamic PET. Herholz K; Rudolf J; Heiss WD J Neurooncol; 1992 Feb; 12(2):159-65. PubMed ID: 1560262 [TBL] [Abstract][Full Text] [Related]
12. In vivo imaging of glucose consumption and lactate concentration in human gliomas. Herholz K; Heindel W; Luyten PR; denHollander JA; Pietrzyk U; Voges J; Kugel H; Friedmann G; Heiss WD Ann Neurol; 1992 Mar; 31(3):319-27. PubMed ID: 1637139 [TBL] [Abstract][Full Text] [Related]
13. Glucose utilization of cerebral gliomas measured by [18F] fluorodeoxyglucose and positron emission tomography. Di Chiro G; DeLaPaz RL; Brooks RA; Sokoloff L; Kornblith PL; Smith BH; Patronas NJ; Kufta CV; Kessler RM; Johnston GS; Manning RG; Wolf AP Neurology; 1982 Dec; 32(12):1323-9. PubMed ID: 6983044 [TBL] [Abstract][Full Text] [Related]
14. [An analysis of 18FDG kinetic rate constants using dynamic positron emission tomography in human brain tumors]. Yamaguchi T; Sasaki H; Uemura K; Shishido F; Inugami A; Ogawa T; Higano S; Mineura K; Kanno I; Murakami M Kaku Igaku; 1986 Jun; 23(6):829-32. PubMed ID: 3489854 [No Abstract] [Full Text] [Related]
15. Effects of hyperglycemia on FDG uptake in human brain and glioma. Ishizu K; Nishizawa S; Yonekura Y; Sadato N; Magata Y; Tamaki N; Tsuchida T; Okazawa H; Miyatake S; Ishikawa M J Nucl Med; 1994 Jul; 35(7):1104-9. PubMed ID: 8014665 [TBL] [Abstract][Full Text] [Related]
16. [Tomographic mapping of rate constants of [F-18] FDG model]. Sasaki H; Kanno I; Miura S; Murakami M; Takahashi K; Shishido F; Uemura K Kaku Igaku; 1985 Jan; 22(1):81-4. PubMed ID: 3873558 [No Abstract] [Full Text] [Related]
17. Clinical value of PET with 18F-fluorodeoxyglucose and L-methyl-11C-methionine for diagnosis of recurrent brain tumor and radiation injury. Ogawa T; Kanno I; Shishido F; Inugami A; Higano S; Fujita H; Murakami M; Uemura K; Yasui N; Mineura K Acta Radiol; 1991 May; 32(3):197-202. PubMed ID: 2064862 [TBL] [Abstract][Full Text] [Related]
18. Diagnostic value of kinetic analysis using dynamic 18F-FDG-PET in patients with malignant primary brain tumor. Kimura N; Yamamoto Y; Kameyama R; Hatakeyama T; Kawai N; Nishiyama Y Nucl Med Commun; 2009 Aug; 30(8):602-9. PubMed ID: 19521265 [TBL] [Abstract][Full Text] [Related]
19. [In vivo measurements of regional cerebral hemocirculation and metabolism in gliomas using 15O and 18F-fluorodeoxyglucose positron emission tomography]. Mineura K; Yasuda T; Kowada M; Shishido F; Ogawa T; Uemura K No To Shinkei; 1986 Apr; 38(4):337-44. PubMed ID: 3013262 [TBL] [Abstract][Full Text] [Related]